Gainers
- Longeveron LGVN stock rose 48.6% to $3.27 during Friday's after-market session. The company's market cap stands at $8.2 million.
- Adial Pharmaceuticals ADIL shares increased by 11.96% to $1.31. The market value of their outstanding shares is at $2.1 million.
- Etao International Co ETAO stock moved upwards by 11.11% to $2.7. The market value of their outstanding shares is at $13.8 million.
- 180 Life Sciences ATNF shares rose 7.35% to $2.39. The market value of their outstanding shares is at $1.7 million.
- Inovio Pharmaceuticals INO stock rose 6.99% to $12.62. The market value of their outstanding shares is at $294.9 million.
- Gossamer Bio GOSS stock increased by 6.79% to $1.1. The market value of their outstanding shares is at $248.1 million.
Losers
- Elicio Therapeutics ELTX stock declined by 10.3% to $7.94 during Friday's after-market session. The market value of their outstanding shares is at $81.1 million.
- SINTX Techs SINT shares decreased by 4.9% to $0.02. The market value of their outstanding shares is at $1.1 million.
- Cerus CERS stock fell 4.82% to $1.78. The market value of their outstanding shares is at $322.6 million.
- MediciNova MNOV shares declined by 4.7% to $1.42. The company's market cap stands at $69.6 million.
- Vor Biopharma VOR stock fell 4.63% to $2.06. The market value of their outstanding shares is at $140.4 million.
- Stoke Therapeutics STOK stock declined by 4.33% to $12.03. The market value of their outstanding shares is at $623.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ATNF180 Life Sciences Corp
$2.6541.7%
CERSCerus Corp
$1.601.27%
ELTXElicio Therapeutics Inc
$5.00-0.60%
GOSSGossamer Bio Inc
$0.8301-3.25%
INOInovio Pharmaceuticals Inc
$1.832.23%
LGVNLongeveron Inc
$1.74-1.69%
MNOVMediciNova Inc
$2.09-1.41%
SINTSINTX Technologies Inc
$3.71-1.33%
STOKStoke Therapeutics Inc
$11.32-2.50%
VORVor Biopharma Inc
$0.8365-3.64%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in